Congestion - that bunged up, stuffy nose ­feeling - is usually a fleeting symptom of a cold which lasts for around a week and ...

A 70-year-old man presented to Tufts emergency department with a 2-day history of left eye redness and periorbital swelling ...

Many people suffer from sinusitis during seasonal changes, experiencing persistent nasal congestion and yellow mucus. The Chosun Ilbo’s medical and health YouTube channel, Kim Chul-jung’s *This Will ...

Dr. Gregory Levitin, a board-certified Otolaryngologist and Director of Open Sinus in New York City, has revolutionized a pain-free, non-surgical approach ...

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published ...

In the news release, NYC Top ENT Doctor Dr. Gregory Levitin Innovates Office Balloon Sinuplasty with a Pain-Free, Non-Surgical Approach in New York City, issued 29-Oct-2025 by Open Sinus over PR ...

At Open Sinus Ear, Nose & Throat, nationally renowned ENT specialist Dr. Gregory Levitin has redefined how chronic sinus conditions are treated in New York City. As the only physician in the city who ...

Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...

'It just started making the day a little bit easier and that snowballed really quickly,' says Stevie A WOMAN was left with a “snowballing” addiction after being prescribed painkillers post-surgery, ...

Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...

"For people living with CRSwNP, every breath can feel like a struggle, and many endure years of recurring symptoms and surgeries without significant relief. The approval of TEZSPIRE represents a ...

(Reuters) -The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus disease, the drugmakers said on Friday. The approval expands the use ...